{"id":"W2095826876","doi":"10.1016/s1470-2045(09)70334-1","title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1187,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ipilimumab; Adverse effect; Clinical endpoint; Internal medicine; Melanoma; Clinical trial; Intention-to-treat analysis; Phases of clinical research; Randomized controlled trial; Gastroenterology; Surgery; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016576,0.002310963,0.004962175,0.0006056585,0.0005166639,0.001338097,0.0010525,0.002441659,0.0056446],"category_scores_gemma":[0.001656699,0.001240856,0.001833938,0.0007572002,0.001469574,0.001712346,0.0005779857,0.003744387,0.001444455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007752011,"about_ca_system_score_gemma":0.001092387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000879898,"about_ca_topic_score_gemma":0.001389656,"domain_scores_codex":[0.9992082,0.0003692177,0.00004444033,0.0001663354,0.0000569312,0.0001549947],"domain_scores_gemma":[0.9990076,0.0002482396,0.0001949669,0.000117542,0.00005947424,0.0003722003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9740831,0.008385796,0.000772359,0.0003182663,0.0005908835,0.00003380122,0.00005913021,0.0003239255,0.005098063,0.00003818953,0.0004028585,0.009893635],"study_design_scores_gemma":[0.9069921,0.08911771,0.0026323,0.00001261603,0.0003545155,0.00002278652,0.00001640088,0.0002174821,0.0002554864,0.00005641118,0.0003060573,0.00001604886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929788,0.002140452,0.0004805416,0.0004178372,0.0003117535,0.001905016,0.000596108,0.00007542758,0.001094116],"genre_scores_gemma":[0.9878253,0.002428534,0.001279916,0.00119523,0.0005566459,0.002728543,0.001014069,0.00003600035,0.002935729],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0056446,"threshold_uncertainty_score":0.01888305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03300815461349548,"score_gpt":0.3521155906350885,"score_spread":0.319107436021593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}